COMPANY

b-rayZ
Healthcare technology company based in Zurich, Switzerland
Founded 2019Zurich, Switzerland
Product: b-box plus Company: b-rayZ
European Radiology, 2025
Enhance mammography quality to increase cancer detection by implementing continuous AI-driven feedback mechanisms, ensuring reliable, consistent, and high-quality screening by the ‘Perfect’, ‘Good’, ‘Moderate’, and ‘Inadequate’ (PGMI) criteria.
To assess the impact of the AI software ‘b-boxTM’ on mammography quality, we conducted a comparative analysis of PGMI scores. We evaluated scores 50 days before (A) and after the software’s implementation in 2021 (B), along with assessments made in the first week of August 2022 (C1) and 2023 (C2), comparing them to evaluations conducted by two readers. Except for postsurgical patients, we included all diagnostic and screening mammograms from one tertiary hospital.
A total of 4577 mammograms from 1220 women (mean age: 59, range: 21–94, standard deviation: 11.18) were included. 1728 images were obtained before (A) and 2330 images after the 2021 software implementation (B), along with 269 images in 2022 (C1) and 250 images in 2023 (C2). The results indicated a significant improvement in diagnostic image quality (p < 0.01). The percentage of ‘Perfect’ examinations rose from 22.34% to 32.27%, while ‘Inadequate’ images decreased from 13.31% to 5.41% in 2021, continuing the positive trend with 4.46% and 3.20% ‘inadequate’ images in 2022 and 2023, respectively (p < 0.01).
Using a reliable software platform to perform AI-driven quality evaluation in real-time has the potential to make lasting improvements in image quality, support radiographers’ professional growth, and elevate institutional quality standards and documentation simultaneously.